0000000000477379

AUTHOR

C. Benito

showing 3 related works from this author

Measurement of CP asymmetry in Bs0 → Ds ∓K± decays

2014

Journal of high energy physics 2018(3), 59 (2018). doi:10.1007/JHEP03(2018)059

B physicCKM angle gamma01 natural sciencesB physicsLuminosityFlavor physicsHadron-Hadron scattering (experiments)TOOLLHCb - Abteilung HintonQCmedia_commonPhysicsParticle physicsCharge conjugation parity time reversal and other discrete symmetrie12.15.HhB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron ScatteringJustice and Strong InstitutionsCP violationB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron Scattering; Nuclear and High Energy PhysicsFísica nuclearLHCAstrophysics::Earth and Planetary AstrophysicsParticle physicsNuclear and High Energy PhysicsVIOLATIONSDG 16 - PeaceVIOLATION; GAMMA; TOOLAstrophysics::High Energy Astrophysical Phenomenamedia_common.quotation_subject14.40.NdLHCb - Abteilung HofmannAstrophysics::Cosmology and Extragalactic AstrophysicsHadrons530Determination of Cabibbo-Kobayashi & Maskawa (CKM) matrix elementAsymmetryNOHadronic decays of bottom mesonTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530010306 general physicsLarge Hadron Collider (France and Switzerland)Astrophysics::Galaxy AstrophysicsHadron-Hadron Scattering010308 nuclear & particles physicsSDG 16 - Peace Justice and Strong InstitutionsGran Col·lisionador d'HadronsGAMMA/dk/atira/pure/sustainabledevelopmentgoals/peace_justice_and_strong_institutionsHEPLHCbFlavor physic13.25.HwB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron scattering (experiments)lcsh:QC770-798Bottom mesons (|B|>0)11.30.ErHigh Energy Physics::ExperimentB physics CKM angle gamma CP violation Flavor physics Hadron-Hadron ScatteringFísica de partículesExperiments
researchProduct

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

2020

Abstract Background High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed …

Male0301 basic medicinePsychological interventionHuman immunodeficiency virus (HIV)MedizinContinuum of care; Europe; HIV infection; Key population; Sex; Anti-Retroviral Agents; Continuity of Patient Care; European Union; HIV; Humans; Male; HIV InfectionsHIV InfectionsContinuum of care; Europe; HIV infection; Key population; Sexmedicine.disease_causekey population0302 clinical medicineContinuum of careHIV Infection030212 general & internal medicineMen having sex with menContinuum of caremedia_commoneducation.field_of_study[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTransmission (medicine)Continuity of Patient CareEuropeInfectious DiseasesAcademicSubjects/MED00290Anti-Retroviral AgentsHIV infection continuum of care sex key population EuropeSexMicrobiology (medical)PopulationSocio-culturale03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)SDG 3 - Good Health and Well-beingmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unioneducationPandemicsHIV infection ; continuum of care ; sex ; key population ; Europebusiness.industrySARS-CoV-2COVID-19HIVmedicine.diseaseHIV infectioncontinuum of care030112 virologyMajor Articles and CommentariesKey populationAnti-Retroviral Agentbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

LAB-STEM CELLS

2012

AbstractsCancer ResearchOncologybusiness.industryMedicineNeurology (clinical)Stem cellbusinessCell biologyNeuro-Oncology
researchProduct